Status and phase
Conditions
Treatments
About
A multi-center, randomized, open-label, group controlled study to evaluate the safety and efficacy of T101 combined with nucleoside (acid) analogues in chronic hepatitis B patients.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Patients must meet all the following inclusion criteria to be enrolled in this study:
Exclusion criteria
Patients with any of the following items will not be enrolled in this study:
Primary purpose
Allocation
Interventional model
Masking
100 participants in 4 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal